Telomeres, the protective caps at the end of DNA strands, shorten over time, leading to cellular ageing and eventual cell death
Tirzepatide is a GIP and GLP-1 receptor antagonist that should be approved for weight loss this year by the FDA
These medications work by mimicking hormones in the body that regulate blood sugar and appetite, leading to: A longer-lasting feeling of fullness after meals Decreased hunger and fewer cravings Improved insulin function and metabolic health More consistent blood sugar levels When combined with lifestyle changes, these treatments can lead to significant, sustainable weight loss
This is consistent with other studies that have implicated the involvement of the mitochondria-dependent intrinsic apoptotic pathway through an NF-B-regulated, mitochondria-mediated pathway involving the activation of reactive oxygen species [307, 308] and the promotion of endoplasmic reticulum stress-mediated mitochondrial apoptosis via the IRE1/ASK1/JNK/Bcl-2 family protein pathways [308]
Current and future treatments in alzheimer disease: an update
